Paterson W, Camilleri M, Simren M et al. Breath testing consensus guidelines for SIBO: RES IPSA LOCQUITOR. Am J Gastroenterol 2017 (this issue).
Rezaie A, Buresi M, Lembo A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the north american consensus. Am J Gastroenterol 2017;112:775–784.
Ford AC, Bercik P, Morgan DG et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013;145:1262–70 e1.
Rana SV, Sharma S, Malik A et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci 2013;58:2594–2598.
Lupascu A, Gabrielli M, Lauritano EC et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157–1160.
Abbasi MH, Zahedi M, Darvish Moghadam S et al. Small bowel bacterial overgrowth in patients with irritable bowel syndrome: the first study in iran. Middle East J Dig Dis 2015;7:36–40.
Parodi A, Paolino S, Greco A et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 2008;6:759–764.
Parodi A, Sessarego M, Greco A et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 2008;103:1257–1262.
Ghoshal UC, Ghoshal U, Das K et al. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006;25:6–10.
Therrien A, Bouchard S, Sidani S et al. Prevalence of small intestinal bacterial overgrowth among chronic pancreatitis patients: a case-control study. Can J Gastroenterol Hepatol 2016;2016:7424831.
Agnoletti AF, DE Col E, Parodi A et al. Etiopathogenesis of rosacea: a prospective study with a three-year follow-up. G Ital Dermatol Venereol 2017;152:418–423.
Park JH, Park DI, Kim HJ et al. The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome. Gut Liver 2009;3:174–179.
Mancilla AC, Madrid SA, Hurtado HC et al. Small intestine bacterial overgrowth in patients with chronic pancreatitis. Rev Med Chil 2008;136:976–980.
Lasa JS, Zubiaurre I, Fanjul I et al. Small intestinal bacterial overgrowth prevalence in celiac disease patients is similar in healthy subjects and lower in irritable bowel syndrome patients. Rev Gastroenterol Mex 2015;80:171–174.
Fasano A, Bove F, Gabrielli M et al. The role of small intestinal bacterial overgrowth in Parkinson's disease. Mov Disord 2013;28:1241–1249.
Kim DB, Paik CN, Sung HJ et al. Breath hydrogen and methane are associated with intestinal symptoms in patients with chronic pancreatitis. Pancreatology 2015;15:514–518.
Lee KN, Lee OY, Koh DH et al. Association between symptoms of irritable bowel syndrome and methane and hydrogen on lactulose breath test. J Korean Med Sci 2013;28:901–907.
Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 2005;100:1566–1570.
Zhao J, Zheng X, Chu H et al. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients. Neurogastroenterol Motil 2014;26:794–802.
Morken MH, Nysaeter G, Strand EA et al. Lactulose breath test results in patients with persistent abdominal symptoms following Giardia lamblia infection. Scand J Gastroenterol 2008;43:141–145.
Posserud I, Stotzer PO, Bjornsson ES et al. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007;56:802–808.
Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008;103:958–963.